Antonia Sophocleous1, Roy Robertson2, Nuno B Ferreira3, James McKenzie4, William D Fraser5, Stuart H Ralston6. 1. Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK. 2. Muirhouse Medical Group, Edinburgh, UK; Centre for Population Health Sciences, University of Edinburgh, UK. 3. Department of Clinical and Health Psychology, University of Edinburgh, UK. 4. Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK; Muirhouse Medical Group, Edinburgh, UK. 5. Department of Medicine, University of East Anglia, Norwich, UK. 6. Rheumatology and Bone Diseases Unit, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK. Electronic address: Stuart.Ralston@ed.ac.uk.
Abstract
PURPOSE: To investigate possible associations between recreational cannabis use and bone health in humans. METHODS: Cross-sectional study of individuals recruited from primary care in the UK between 2011 and 2013. Cases were regular smokers of cannabis divided into moderate (n = 56) and heavy user (n = 144) subgroups depending on whether they reported fewer or more than 5000 cannabis smoking episodes during their lifetime. Controls comprised 114 cigarette smokers. RESULTS: Heavy cannabis users had lower total hip bone mineral density (mean ± SD Z-score: -0.20 ± 0.9 vs +0.2 ± 0.9, P < .0005), lower spine bone mineral density (-0.5 ± 1.2 vs 0.0 ± 1.2, P < .0005), and lower body mass index (BMI; 26.5 ± 6.0 vs 29.0 ± 7.0, P = .01) than controls. Fracture rate was also increased in heavy users (rate ratio = 2.17; 95% confidence interval, 1.59-2.95; P < .001). When compared with controls, serum cross-linked C-telopeptide of type 1 collagen (CTX) concentrations were raised in heavy cannabis users (0.3 ± 0.1 vs 0.2 ± 0.1 pg/mL, P = .045), as were serum N-terminal propeptide of type 1 procollagen (P1NP) concentrations (47.1 ± 19.2 vs 41.2 ± 17.8 pg/mL, P = .01). Serum total 25-hydroxyvitamin D concentrations were reduced in heavy users compared with controls (25.3 ± 16.8 vs 36.9 ± 26.7 nmol/L, P = .002). Multiple regression analysis revealed that heavy cannabis use was an independent predictor of spine bone mineral density, accounting for 5.4% of the variance (P = .035), and total hip bone mineral density, accounting for 5.8% of the variance (P = .001), but mediation analysis suggested that the effect on spine bone mineral density was indirect and mediated through low body mass index. CONCLUSIONS: Heavy cannabis use is associated with low bone mineral density, low BMI, high bone turnover, and an increased risk of fracture. Heavy cannabis use negatively impacts on bone health both directly and indirectly through an effect on BMI.
PURPOSE: To investigate possible associations between recreational cannabis use and bone health in humans. METHODS: Cross-sectional study of individuals recruited from primary care in the UK between 2011 and 2013. Cases were regular smokers of cannabis divided into moderate (n = 56) and heavy user (n = 144) subgroups depending on whether they reported fewer or more than 5000 cannabis smoking episodes during their lifetime. Controls comprised 114 cigarette smokers. RESULTS: Heavy cannabis users had lower total hip bone mineral density (mean ± SD Z-score: -0.20 ± 0.9 vs +0.2 ± 0.9, P < .0005), lower spine bone mineral density (-0.5 ± 1.2 vs 0.0 ± 1.2, P < .0005), and lower body mass index (BMI; 26.5 ± 6.0 vs 29.0 ± 7.0, P = .01) than controls. Fracture rate was also increased in heavy users (rate ratio = 2.17; 95% confidence interval, 1.59-2.95; P < .001). When compared with controls, serum cross-linked C-telopeptide of type 1 collagen (CTX) concentrations were raised in heavy cannabis users (0.3 ± 0.1 vs 0.2 ± 0.1 pg/mL, P = .045), as were serum N-terminal propeptide of type 1 procollagen (P1NP) concentrations (47.1 ± 19.2 vs 41.2 ± 17.8 pg/mL, P = .01). Serum total 25-hydroxyvitamin D concentrations were reduced in heavy users compared with controls (25.3 ± 16.8 vs 36.9 ± 26.7 nmol/L, P = .002). Multiple regression analysis revealed that heavy cannabis use was an independent predictor of spine bone mineral density, accounting for 5.4% of the variance (P = .035), and total hip bone mineral density, accounting for 5.8% of the variance (P = .001), but mediation analysis suggested that the effect on spine bone mineral density was indirect and mediated through low body mass index. CONCLUSIONS: Heavy cannabis use is associated with low bone mineral density, low BMI, high bone turnover, and an increased risk of fracture. Heavy cannabis use negatively impacts on bone health both directly and indirectly through an effect on BMI.
Authors: Tsun Yee Law; Jennifer Kurowicki; Samuel Rosas; Karim Sabeh; Spencer Summers; Zachary Hubbard; Martin Roche Journal: J Long Term Eff Med Implants Date: 2018
Authors: Tarek Alhamad; Farrukh M Koraishy; Ngan N Lam; Sreelatha Katari; Abhijit S Naik; Mark A Schnitzler; Huiling Xiao; David A Axelrod; Vikas R Dharnidharka; Henry Randall; Rosemary Ouseph; Dorry L Segev; Daniel C Brennan; Radhika Devraj; Bertram L Kasiske; Krista L Lentine Journal: Transplantation Date: 2019-11 Impact factor: 4.939
Authors: Neil V Shah; Joshua D Lavian; Cameron R Moattari; Hassan Eldib; George A Beyer; David H Mai; Vincent Challier; Peter G Passias; Renaud Lafage; Virginie Lafage; Frank J Schwab; Carl B Paulino; Bassel G Diebo Journal: Iowa Orthop J Date: 2022-06
Authors: Ian R Reynolds; Danielle R Fixen; Bennett L Parnes; Hillary D Lum; Prajakta Shanbhag; Skotti Church; Sunny A Linnebur; Gretchen Orosz Journal: J Am Geriatr Soc Date: 2018-10-06 Impact factor: 5.562